The structural genes for Shiga toxin, designated stx A and stx B, were cloned from Shigella dysenteriae type 1 3818T, and a nucleotide sequence analysis was performed. Both stx A and stx B were present on a single transcriptional unit, with stx A preceding stx B. The molecular weight calculated for the processed A subunit was 32,225, while the molecular weight of the processed B subunit was 7,691. Comparison of the nucleotide sequences for Shiga toxin and Shiga-like toxin I (SLT-I) from Escherichia coli revealed that the genes for Shiga toxin and SLT-I were greater than 99% homologous; three nucleotide changes were detected in three separate codons of the A subunits. Only one of these codon differences resulted in a change in the amino acid sequence: a threonine in Shiga toxin at position 45 of the A subunit compared with a serine in the corresponding position in SLT-I. Furthermore, Shiga toxin and SLT-I had identical signal peptides for the A and B subunits, as well as identical ribosome-binding sites, a putative promoter, and iron-regulated operator sequences. These findings indicate that Shiga and SLT-I are essentially the same toxin. Southern hybridization studies with total cellular DNA from several Shigella strains and internal toxin probes for SLT-I and its antigenic variant SLT-II showed that a single fragment in S. dysenteriae type 1 hybridized strongly with the internal SLT-I probe. Fragments with weaker homology to the SLT-I probe were detected in S. flexneri type 2a but no other shigellae. No homology between the Shiga-like toxin II (SLT-II) probe and any of the Shigella DNAs was detected. Whereas SLT-I and SLT-II are phage encoded, no phage could be induced from S. dysenteriae type 1 or other Shigella spp. tested. These results suggest that the Shiga (SLT-I) toxin genes responsible for high toxin production are present in a single copy in S. dysenteriae type 1 but not in other shigellae. The findings further suggest that SLT-II genes are absent in shigellae, as are toxin-converting phages.
Shiga toxin is a cell-associated protein toxin composed of one copy of an A subunit (molecular weight estimated as 32,000) and five copies of a B subunit (molecular weight estimated as 7,700) (8, 38) . The toxin inhibits protein synthesis in eucaryotic cells by cleaving the N-glycosidic bond at adenine 4324 in 28S rRNA (Y. Endo, K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi, Eur. J. Biochem., in press). The mode of action of Shiga toxin is therefore identical to that of the plant toxin ricin (10) . The biological and biochemical properties of Shiga toxin have recently been reviewed by O'Brien and Holmes (27) .
Shigella species other than Shigella dysenteriae type 1 and certain strains of Escherichia coli, Salmonella typhimurium, Vibrio cholerae, and Campylobacter jejuni produce low levels of a cytotoxin(s) that is neutralizable by antibodies against purified Shiga toxin from S. dysenteriae type 1 (30, 32; A. D. O'Brien, M. E. Chen, R. K. Holmes, J. Kaper, and M. Levine, Letter, Lancet, i:77-78, 1984; M. A. Moore, M. J. Blazer, G. I. Perez-Perez, and A. D. O'Brien, submitted for publication). Some strains of E. coli produce toxin in amounts equivalent to those produced by strains of S. dysenteriae type 1 (23, 30) . E. coli that produce such elevated levels of toxin have been associated with outbreaks and sporadic cases of diarrhea (5, 37) , hemorrhagic colitis (23, 34) , and hemolytic uremic syndrome (19, 23) .
Toxins produced by organisms other than S. dysenteriae type 1 that are neutralizable with antibodies against purified Shiga toxin are referred to as Shiga-like toxins (SLTs). The SLT produced at high levels by E. coli, SLT-I, is also referred to as Vero toxin or Vero toxin type 1 due to its cytotoxic activity on Vero cells. The immunological, biological, and biochemical properties of purified Shiga toxin and purified SLT-I from E. coli are virtually identical (28, 42; A. D. O'Brien, T. A. Lively, T. W. Chang, and S. L. Gorbach, Letter, Lancet ii:573, 1983).
The E. coli SLT-I structural genes (slt-I A and slt-I B) are carried on temperate bacteriophages (31, 41) . The amino acid compositions of the SLT-I A and B subunits predicted from the DNA sequences (3, 7, 18) are nearly identical to the amino acid compositions of the A and B subunits of Shiga toxin experimentally determined by Donohue-Rolfe et al. (8) . In addition, the predicted amino acid sequence of the B subunit of SLT-I (3, 7, 18) is identical to the amino acid sequence of the B subunit of Shiga toxin experimentally determined by Seidah et al. (38) , and the amino acid sequence of the A subunit shares limited homology with the A subunit of ricin (3, 7) . An (24) . The E. coli minicell-producing strain P678-54 described by Adler et al.
(1) was obtained from C. L. Pickett of the Uniformed Services University (Bethesda, Md.). Cosmid pHC79 (15) was used for the initial cloning; and plasmids pBR322, pBR328, pACYC184, pUC18, and pUC19 were used for subcloning as described by Maniatis et al. (22) . Recombinant plasmid pJN25 was described by Newland et al. (26) and carries the intact structural genes for SLT-I. Recombinant plasmids pJN31, containing a 250-base-pair (bp) HindIII to HpaI internal fragment from the slt-I A gene, and pNN76, containing a 5-kilobase-pair (kbp) EcoRI fragment, including the slt-II A and B genes, were obtained from J. W. Newland of the Walter Reed Army Institute of Research.
Media, enzymes and biochemicals. Bacteria were routinely cultured in LB medium (22) . Strains tested for toxin production were grown in Chelex-treated glucose syncase medium (30) or Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.). Media were supplemented as indicated in the text with the following antibiotics (Sigma Chemical Co., St. Louis, Mo.) at the indicated concentrations: ampicillin, 100 ,ug/ml; tetracycline, 15 p.g/ml; and chloramphenicol, 30 Preparation of plasmid, cellular, and phage DNA. Plasmid and cellular DNAs were prepared by the method described by Maniatis et al. (22) . Phage from E. coli C600(933J) or E. coli C600(933W) was obtained after induction with mitomycin C by previously described methods (12) . Phage DNA was extracted with formamide by previously published proce-dures (6) . Lambda DNA was purchased from Bethesda Research Laboratories.
Phage induction. Experiments to induce phage from S. dysenteriae type 1 3818T and 60R, S. flexneri M4243, S. sonnei SF-sl, and S. boydii SF-bl with UV light or mitomycin C were performed as described previously (12, 31) . E. coli HB101 and E. coli C600 were used as hosts to plaque phage.
Cloning and subcloning. Cloning of the Shiga toxin genes from S. dysenteriae type 1 3818T and all manipulations of toxin-positive clones were conducted under BL3-EK1 containment (11) . Cosmid cloning was performed essentially as described by Maniatis et al. (22) . Transductants were screened for toxin production with a colony blot assay which immunochemically detects the B subunit of Shiga toxin (42) . Colony blot-positive transductants were tested for biologically active toxin by the HeLa cell cytotoxicity assay (14) . Neutralization of cytotoxicity was performed with rabbit antiserum against purified Shiga toxin (29), rabbit antiserum against crude SLT-II (43), a mixture of anti-Shiga and anti-SLT-II, and monoclonal antibody (MAb) 13C4 produced against SLT-I (42). Normal rabbit serum and MAbs against cholera toxin (16) were used as control antibodies.
Cytotoxicity and neutralization assays. Bacteria were assayed for toxin as described previously (30) , and neutralization assays were performed by previously published methods (23) .
Minicell analysis and immunoprecipitation. Minicell experiments were performed by the method described by Meagher et al. (25) . The labeled proteins were extracted with polymyxin B (100 ,ug/ml) for 45 min at 37°C and then analyzed on sodium dodecyl sulfate-15% polyacrylamide gels (21) . Immunoprecipitation of the extracted proteins was performed essentially as described by Kessler (20) . Rabbit antisera (100 ,lI of a 1:100 dilution of anti-Shiga or normal rabbit serum) or MAbs (100 ,ul of ammonium sulfate-concentrated culture supernatants) of anti-SLT-I (MAb 13C4 or MAb 16E6) or anti-cholera toxin (MAb 32D3) were mixed overnight at 4°C with the labeled proteins (106 cpm per sample). The following day a second antibody (1 ,ul of goat anti-mouse immunoglobulin G [IgG] and IgM heavy and light chains; Boehringer Mannheim) was added to facilitate precipitation. The samples were incubated for an additional hour at 37°C, and then the antibody-antigen complexes were precipitated with Pansorbin (Calbiochem-Behring, La Jolla, Calif.) as described previously (20) .
Southern hybridizations. Southern transfer of DNA and DNA-DNA hybridizations were performed as described by Maniatis et al. (22) . EcoRI-restricted DNA samples from SLT-I phage 933J and from SLT-II phage 933W were nick translated and used as probes to detect homologous phage sequences in EcoRI-digested total cellular DNA preparations. Internal DNA probes from the SLT-I and SLT-II A subunit genes were prepared by published procedures (9) . The SLT-I probe was a 250-bp HindIII to HpaI fragment from pJN31, and the SLT-II probe was an 800-bp SmaI to PstI fragment from pNN76. Nucleotide sequence analysis. Subfragments of the recombinant plasmid pNAS4 were cloned into the M13 mpl8 and mpl9 replicative-form vectors (36) to allow determination of the nucleotide sequence of the Shiga toxin genes. Synthetic oligonucleotides (model 380A DNA synthesizer; Applied Biosystems, Inc., Foster City, Calif.) specific to the SLT-I nucleotide sequence (18) were used as primers in the dideoxy chain-terminator method (2) . The sequencing strategy is depicted in Fig. 1 . The amino acid sequences and biochem-ical properties of the Shiga toxin A and B subunits were deduced with a DNA computer program (IBI/Pustell). A computer search of GenBank (MicroGenie; Beckman Instruments, Inc., Palo Alto, Calif.) revealed no significant homologies with bacterial or bacteriophage sequences. RESULTS Cloning of toxin genes. The genes for Shiga toxin were cloned from total cellular DNA isolated from S. dysenteriae type 1 3818T with the cosmid vector pHC79. Transductants were initially screened for production of the B subunit with a colony blot assay. Of 750 transductants screened, 3 carried recombinant plasmids, designated pNAS1, pNAS2, and pNAS3, which produced the B subunit. Transductants carrying pNAS2 or pNAS3 produced biologically active toxin, as assayed in the HeLa cell cytotoxicity assay. The cytotoxin produced by these two transductants was neutralizable with polyclonal antibodies against purified Shiga toxin and MAbs against SLT-I. The toxin was not neutralizable with polyclonal antibodies against crude SLT-II.
Digestion of plasmid DNAs from pNAS1, pNAS2, and pNAS3 with HindIII, EcoRV, and EcoRI revealed common restriction fragments. Digestion of pNAS2 and pNAS3 with EcoRI showed a common fragment of approximately 5 kbp that was absent in the nontoxigenic plasmid pNAS1. This 5-kbp EcoRI fragment was subcloned from pNAS2 into the vector pACYC184 to produce the hybrid plasmid pNAS4 which carried the intact genes for Shiga toxin production. A restriction map of the 5 kbp EcoRI fragment and the strategy for subcloning and sequence analysis are shown in Fig. 1 . From the subcloning and sequence analyses, the A-and B-subunit genes for Shiga toxin were located within a 3.2-kbp NcoI to EcoRI fragment, between the BglII and HincIl restriction sites.
Minicell analysis. The polypeptides encoded by pNAS4 were analyzed in minicell experiments ( Fig. 2A ). The results with minicells showed that pNAS4 encodes polypeptides with the same apparent molecular weights as the SLT-I A and B polypeptides encoded by pJN25, a recombinant plasmid carrying the intact structural genes for SLT-I (26) . An A polypeptide with a molecular weight of approximately 32,500 and a B polypeptide with a molecular weight of approximately 8,000 were identified from the minicells trans-EcoRI pNAS4 L formed with pNAS4. Higher-molecular-weight forms (presumed to be unprocessed polypeptides with signal sequences) of the Shiga toxin and SLT-I A and B subunits were also encoded by minicells ( Fig. 2A ). The processed and unprocessed forms of the A and B polypeptides were absent in the minicells carrying the vector plasmid pACYC184.
The radiolabeled toxins produced by minicells containing pNAS4 or pJN25 were immunoprecipitated with either rabbit antiserum against purified Shiga toxin or MAbs against SLT-I, and were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Polypeptides corresponding in molecular weights to the processed A subunit (Mr, 32,500), an A1 fragment (Mr, 27,500) which is the product of proteolytic nicking (28) , and the processed B subunit (Mr, 8 ,000) were immunoprecipitated by anti-Shiga or anti-Shigalike antibodies (Fig. 2B) . No polypeptides were precipitated by the control antibodies (normal rabbit serum and anticholera toxin MAbs).
Sequence analysis of toxin genes. In Fig. 3 the nucleotide and deduced amino acid sequences of stx A and stx B are presented and compared with the slt-I A and slt-I B sequences as reported previously (18) . The nucleotide and amino acid sequences for stx A and slt-A differed by three nucleotides, shown at positions 223, 359, and 850 in Fig. 3 . Only one of the three nucleotide differences between stx A and slt-I A caused a change in the amino acid sequences. The adenine to thymine transversion at nucleotide 359 resulted in a substitution (albeit conservative) of a threonine in the Shiga toxin sequence for a serine in the SLT-I sequence. Nucleotide sequences (thus far determined) upstream and downstream to the stx operon were identical to those reported previously for the slt-I operon cloned from phage 933J (18) . The Shiga toxin A and B subunits possessed signal peptides of 22 and 20 amino acids, respectively (designated by negative values in Fig. 3 ), which were identical to the SLT-I A-and B-subunit signal peptides. Separation of the signal peptides from the mature polypeptides at putative E. coli signal peptidase I cleavage sites (33) resulted in a processed Shiga toxin A subunit of 293 amino acids, with a calculated molecular weight of 32,225, and a processed B subunit of 69 amino acids, with a calculated molecular weight of 7,691. The amino acid sequence of the Shiga toxin B subunit deduced from the nucleotide sequence was iden- .- FIG. 1 . Restriction map of Shiga toxin genes. Restriction sites are indicated within the 5-kbp EcoRI fragment isolated from the recombinant plasmid pNAS4. Subclones carrying regions of the 5-kbp EcoRI fragment are shown, and their ability to produce biologically active toxin and antigenically reactive B subunit is indicated on the right of the figure. The Shiga toxin structural genes, stx A and stx B, are oriented above the restriction map. The strategy used to sequence the coding and noncoding strands of stx A and stx B is depicted by the arrows below the map. Arrows preceded by a vertical line indicate subfragments sequenced by using the M13 universal primer. Arrows preceded by a dot indicate where synthetic oligonucleotides specific to the SLT-I sequence were used as primers. tical to that determined previously by using the purified protein (38) .
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The structural genes of the Shiga toxin operon were translated in frame and were organized tandemly with the open reading frame of stx A 5' to the open reading frame of stx B. An untranslated space of 12 nucleotides separated stx A and stx B. A putative promoter sequence (35) was identified 5' to stx A (at nucleotides 19 and 42; underlined in Fig.  3 ). This promoter was the same promoter identified for the slt-I operon (3, 7) . It has been proposed that the sit-I operon is repressed under iron replete conditions by the fur gene product (4), and a putative binding site for the Fur protein was identified in a region of dyad symmetry within the slt-I promoter (4, 7) . Because the promoter sequences of the stx and sit-I operons were identical, it is likely that the negative effect of iron on the expression of Shiga toxin is also mediated by the fur gene product.
Two sequences homologous to the 3' end of E. coli 16S rRNA (40) which could serve as ribosome-binding sites were identified for both stx A and stx B (at nucleotides 145 and 1107, respectively; overlined in Fig. 3 ). Both the sequence and position of the stx ribosome-binding sites were identical to those reported previously for the sit-I operon (18) . The proposed mode of expression for the Shiga toxin operon was identical to that proposed previously (18) for the sit-I operon; i.e., the individual subunits are synthesized from a polycistronic mRNA that is regulated by the promoter 5' to stx A. Translation to give the individual A and B subunits would be initiated from the independent ribosome-binding sites. The existence of an additional ribosome-binding site for stx B may function to give the holotoxin subunit ratio of 5B:1A (8) . However, the effect of two different genetic backgrounds, i.e., S. dysenteriae type 1 compared with E. coii, on the expression of the Shiga toxin (sit-I) operon and on the assembly of the holotoxin has yet to be determined.
Toxin production, phage induction, and Southern hybridization experiments. S. dysenteriae type 1 3818T and 60R, S. flexneri M4243, S. boydii SF-bl, and S. sonnei SF-si were studied for the production of cytotoxin that was antigenically related to SLT-1 or SLT-II and for DNA sequences that were related to the genes for SLT-1 or SLT-II. The results of these experiments are summarized in Table 1 . Various levels of cytotoxin(s) were detected among all four species of Shigeila. However, high-level toxin production (>10' 50% cytotoxic dose per ml of sonic lysate) was observed for S. dysenteriae type 1 3818T and 60R only. The cytotoxic activity detected for all strains of Shigeiia tested was neutralizable with MAbs to SLT-I and not by polyclonal antibodies to crude SLT-II. Southern hybridization experiments performed under conditions that permitted no more than a 30% base-pair mismatch showed strong homology between an internal probe for SLT-1 and single fragments of different sizes from S. dysenteriae type 1 3818T and 60R (Fig. 4A) . With an extended time (11 days), additional bands of weak homology were also detected among S. dysenteriae type 1 3818T and 60R and S. flexneri M4243 (Fig. 4B ), but not among S. sonnei or S. boydii. These fragments appeared to be of the same or similar size in S. dysenteriae type 1 and S. flexneri. Under the hybridization conditions described above, no homology was detected between the internal SLT-II probe and the cellular DNAs from the five strains of Shigelia (data not shown).
The strains described above were also tested for UVor figure. sequences related to the SLT-Ior SLT-II-converting phages from E. coli 933. No phages were detected by using E. coli K-12 C600 and HB101 as the host bacteria for the plaquing experiments ( Table 1) . Total cellular DNA from the five strains of Shigella was probed under hybridization conditions that permitted up to 30%o base-pair mismatch with genomic DNA from SLT-I-converting phage 933J or SLT-II-converting phage 933W. Sequences related to phage 933J were detected in S. dysenteriae type 1 3818T and 60R and S. flexneri M4243, but not in S. sonnei SF-sl or S. boydii SF-bl. No sequences related to phage 933W were detected in any of the strains tested (data not shown).
DISCUSSION
In the studies reported here, the structural genes for Shiga toxin from S. dysenteriae type 1 3818T were cloned and the single amino acid difference between Shiga toxin and SLT-I is shown below the sequence, at residue 45. A putative promoter sequence (35) is underlined at nucleotides 19 to 24 (-35) and 42 to 47 (-10). Two potential ribosome-binding sites (40) are overlined beginning at nucleotides 145 (5' to stx A) and 1107 (5' to stx B). The nucleotide sequence of SLT-I reported previously (18) was corrected here. This sequence contained three fewer T residues in the first 150 bp. nucleotide sequences were determined. The nucleotide sequences of three members of the Shiga toxin gene family, SLT-I (18), SLT-II (17), and Shiga toxin, have now been determined. These sequence analyses define a relationship among the Shiga toxin and SLT genes and suggest models of evolution. We have shown previously (17) that SLT-I and SLT-II share limited regions of high nucleotide sequence homology (greater than 70%) but are only 55% homologous overall. This indicates that the SLT-I and SLT-II genes diverged from each other in the distant past, prior to the evolution of S. dysenteriae type 1 and E. coli as separate genera. In contrast, the Shiga toxin and SLT-I nucleotide sequences were greater than 99% homologous, and translation of the nucleotide sequences revealed that Shiga toxin and SLT-I were essentially identical toxins. This high degree of genetic relatedness would be expected to exist between an individual gene isolated from two separate bacterial strains of the same species. At this time it is not possible to ascertain the origin of the Shiga toxin or SLT-I genes. Since SLT-I is encoded by a temperate coliphage, transduction could serve to disseminate the toxin structural genes among related bacteria. Although attempts to induce phage from several strains of Shigella were unsuccessful (Table 1) , DNA sequences homologous to the SLT-I-converting phage 933J were detected within S. dysenteriae type 1 and S. flexneri type 2A (data not shown). These sequences may represent (i) a defective or incomplete phage in Shigella species which is no longer inducible or (ii) a related phage that is not inducible with either UV light or mitomycin C or does not form plaques on E. coli K-12 HB101 or C600.
The results of this study support the nomenclature established previously (30) for the Shiga-related toxins because they reveal the near identity between the sequences of SLT-I and Shiga toxin. Shigella toxin was described in 1903, prior to the discovery of any related cytotoxins in E. coli or related genera. To avoid confusion, the designation SLT should be used for toxin variants isolated from bacteria other than S. dysenteriae type 1 which share antigenic or biologic properties with Shiga toxin. The designations SLT-I, SLT-II, etc., should be assigned on the basis of the sequence relatedness of a new antigenic variant to the prototypic cytotoxin genes described previously.
A definitive role for Shiga toxin in diarrheal disease has not yet been demonstrated. Studies with nonisogenic strains of Shigella differing in toxin production or invasiveness (an essential virulence trait) have produced inconclusive results about the role of toxin in the pathogenesis of shigellosis (13) .
The data reported here should facilitate the construction of isogenic strains of Shigella that differ only in the ability to produce toxin. These strains could be used in animal studies to clarify the role of Shiga toxin in the pathogenesis of shigellosis and hemolytic uremic syndrome.
